Patient and physician satisfaction with the Humulin®/Humalog® Pen, a new 3.0-mL prefilled pen device for insulin delivery
- 1 September 2000
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 22 (9) , 1049-1067
- https://doi.org/10.1016/s0149-2918(00)80084-3
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Biologic Material in Needles and Cartridges After Insulin Injection With a Pen in Diabetic PatientsDiabetes Care, 1998
- Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agentsDiabetes Research and Clinical Practice, 1998
- Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringeClinical Therapeutics, 1998
- Pen injection and change in metabolic control and quality of life in insulin dependent diabetes mellitusDiabetes Research and Clinical Practice, 1997
- Safety, efficacy, acceptability of a pre-filled insulin pen in diabetic patients over 60 years oldDiabetes Research and Clinical Practice, 1995
- Change in quality of life along with type 1 diabetesDiabetes Research and Clinical Practice, 1995
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Insulin-pen treatment, quality of life and metabolic control: retrospective intra-group evaluationsDiabetes Research and Clinical Practice, 1990